Cross Country Healthcare, Inc.

NasdaqGS:CCRN Voorraadrapport

Marktkapitalisatie: US$383.1m

Cross Country Healthcare Toekomstige groei

Future criteriumcontroles 3/6

Cross Country Healthcare's revenue is forecast to decline at 6.8% per annum while its annual earnings are expected to grow at 71.5% per year. EPS is expected to grow by 71% per annum. Return on equity is forecast to be 4.3% in 3 years.

Belangrijke informatie

71.5%

Groei van de winst

71.0%

Groei van de winst per aandeel

Healthcare winstgroei20.1%
Inkomstengroei-6.8%
Toekomstig rendement op eigen vermogen4.3%
Dekking van analisten

Good

Laatst bijgewerkt21 Oct 2024

Recente toekomstige groei-updates

Recent updates

Cross Country Healthcare: The Strong Balance Sheet Provides A Sufficient Margin Of Safety

Oct 15

Cross Country Healthcare, Inc.'s (NASDAQ:CCRN) Shares Bounce 30% But Its Business Still Trails The Market

Jul 31
Cross Country Healthcare, Inc.'s (NASDAQ:CCRN) Shares Bounce 30% But Its Business Still Trails The Market

Benign Growth For Cross Country Healthcare, Inc. (NASDAQ:CCRN) Underpins Stock's 25% Plummet

Feb 22
Benign Growth For Cross Country Healthcare, Inc. (NASDAQ:CCRN) Underpins Stock's 25% Plummet

Calculating The Intrinsic Value Of Cross Country Healthcare, Inc. (NASDAQ:CCRN)

Feb 09
Calculating The Intrinsic Value Of Cross Country Healthcare, Inc. (NASDAQ:CCRN)

Cross Country Healthcare (NASDAQ:CCRN) Is Achieving High Returns On Its Capital

Oct 09
Cross Country Healthcare (NASDAQ:CCRN) Is Achieving High Returns On Its Capital

Should You Investigate Cross Country Healthcare, Inc. (NASDAQ:CCRN) At US$23.23?

Sep 13
Should You Investigate Cross Country Healthcare, Inc. (NASDAQ:CCRN) At US$23.23?

These 4 Measures Indicate That Cross Country Healthcare (NASDAQ:CCRN) Is Using Debt Reasonably Well

Aug 19
These 4 Measures Indicate That Cross Country Healthcare (NASDAQ:CCRN) Is Using Debt Reasonably Well

Returns on Capital Paint A Bright Future For Cross Country Healthcare (NASDAQ:CCRN)

Jun 26
Returns on Capital Paint A Bright Future For Cross Country Healthcare (NASDAQ:CCRN)

At US$27.39, Is It Time To Put Cross Country Healthcare, Inc. (NASDAQ:CCRN) On Your Watch List?

Jun 08
At US$27.39, Is It Time To Put Cross Country Healthcare, Inc. (NASDAQ:CCRN) On Your Watch List?

Is Cross Country Healthcare (NASDAQ:CCRN) Using Too Much Debt?

Apr 28
Is Cross Country Healthcare (NASDAQ:CCRN) Using Too Much Debt?

Returns on Capital Paint A Bright Future For Cross Country Healthcare (NASDAQ:CCRN)

Mar 15
Returns on Capital Paint A Bright Future For Cross Country Healthcare (NASDAQ:CCRN)

Why Cross Country Healthcare, Inc. (NASDAQ:CCRN) Could Be Worth Watching

Mar 02
Why Cross Country Healthcare, Inc. (NASDAQ:CCRN) Could Be Worth Watching

If EPS Growth Is Important To You, Cross Country Healthcare (NASDAQ:CCRN) Presents An Opportunity

Jan 20
If EPS Growth Is Important To You, Cross Country Healthcare (NASDAQ:CCRN) Presents An Opportunity

Cross Country Healthcare (NASDAQ:CCRN) Has A Rock Solid Balance Sheet

Jan 05
Cross Country Healthcare (NASDAQ:CCRN) Has A Rock Solid Balance Sheet

Is Now The Time To Look At Buying Cross Country Healthcare, Inc. (NASDAQ:CCRN)?

Oct 29
Is Now The Time To Look At Buying Cross Country Healthcare, Inc. (NASDAQ:CCRN)?

Investors Shouldn't Overlook Cross Country Healthcare's (NASDAQ:CCRN) Impressive Returns On Capital

Oct 14
Investors Shouldn't Overlook Cross Country Healthcare's (NASDAQ:CCRN) Impressive Returns On Capital

Paring My Cross Country Healthcare Gains

Sep 29

Should You Be Adding Cross Country Healthcare (NASDAQ:CCRN) To Your Watchlist Today?

Sep 26
Should You Be Adding Cross Country Healthcare (NASDAQ:CCRN) To Your Watchlist Today?

Cross Country Healthcare to acquire assets of Mint Medical Physician Staffing, LP and Lotus Medical Staffing LLC

Sep 14

Cross Country Healthcare (NASDAQ:CCRN) Has A Pretty Healthy Balance Sheet

Aug 21
Cross Country Healthcare (NASDAQ:CCRN) Has A Pretty Healthy Balance Sheet

Cross Country Healthcare rises postmarket on $100M stock buyback program

Aug 16

Cross Country Healthcare Q2 Non-GAAP EPS, revenue beats, Q3 guidance provided

Aug 03

Is Cross Country Healthcare, Inc. (NASDAQ:CCRN) Potentially Undervalued?

Jun 16
Is Cross Country Healthcare, Inc. (NASDAQ:CCRN) Potentially Undervalued?

Winst- en omzetgroeiprognoses

NasdaqGS:CCRN - Toekomstschattingen van analisten en financiële gegevens uit het verleden (USD Millions )
DatumInkomstenInkomstenVrije kasstroomGeldmiddelen uit operationele activiteitenGem. Aantal analisten
12/31/20261,33529N/AN/A4
12/31/20251,3062374828
12/31/20241,349-61141238
6/30/20241,5758159171N/A
3/31/20241,77646195208N/A
12/31/20232,02073235248N/A
9/30/20232,234102228241N/A
6/30/20232,428124298311N/A
3/31/20232,641156200210N/A
12/31/20222,807188125134N/A
9/30/20222,8192274756N/A
6/30/20222,558216-95-87N/A
3/31/20222,136175-98-90N/A
12/31/20211,677132-93-86N/A
9/30/20211,25259-16-10N/A
6/30/20211,07134-21-16N/A
3/31/20219569-20-15N/A
12/31/2020836-132327N/A
9/30/2020836-191520N/A
6/30/2020851-211014N/A
3/31/2020837-58710N/A
12/31/2019822-5836N/A
9/30/2019808-76710N/A
6/30/2019800-742428N/A
3/31/2019801-201621N/A
12/31/2018816-171621N/A
9/30/2018835313439N/A
6/30/2018863383438N/A
3/31/201886841N/A57N/A
12/31/201786538N/A46N/A
9/30/20178682N/A27N/A
6/30/20178549N/A43N/A
3/31/2017845-13N/A29N/A
12/31/20168348N/A30N/A
9/30/201680410N/A32N/A
6/30/20167851N/A25N/A
3/31/201677821N/A21N/A
12/31/20157674N/A18N/A
9/30/2015762-10N/A18N/A
6/30/2015756-22N/A7N/A
3/31/2015686-28N/A5N/A
12/31/2014618-32N/A-4N/A
9/30/2014539-64N/A-6N/A
6/30/2014458-55N/A-1N/A
3/31/2014446-54N/A1N/A
12/31/2013438-54N/A9N/A

Toekomstige groeivoorspellingen analisten

Verdiensten versus spaarpercentage: CCRN's forecast earnings growth (71.5% per year) is above the savings rate (2.5%).

Winst versus markt: CCRN's earnings (71.5% per year) are forecast to grow faster than the US market (15.4% per year).

Hoge groeiwinsten: CCRN's earnings are expected to grow significantly over the next 3 years.

Omzet versus markt: CCRN's revenue is expected to decline over the next 3 years (-6.8% per year).

Hoge groei-inkomsten: CCRN's revenue is forecast to decline over the next 3 years (-6.8% per year).


Groeiprognoses winst per aandeel


Toekomstig rendement op eigen vermogen

Toekomstige ROE: CCRN's Return on Equity is forecast to be low in 3 years time (4.3%).


Ontdek groeibedrijven